IMMUNOPRECISE ANTIBODIES LTD (IPA)
CA45257F2008 - Common Stock
| TTM (2024-10-31) | 2024 (2024-4-30) | 2023 (2023-4-30) | 2022 (2022-4-30) | 2021 (2021-4-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -27.54M | -27.18M | -26.56M | -16.71M | -7.34M | |||
| Depreciation Amortization | 5.70M | 5.74M | 6.68M | 3.77M | 3.71M | |||
| Income Taxes - Deferred | -2.33M | -1.77M | -926.00K | -336.00K | -83.00K | |||
| Change In Working Capital | 798.00K | 2.37M | -3.28M | 582.00K | -1.02M | |||
| Interest Paid | 0.00 | 0.00 | 263.00K | 38.00K | 120.00K | |||
| Taxes Paid | 0.00 | 0.00 | 591.00K | 1.19M | 1.10M | |||
| Other non cash items | 16.00M | 16.60M | 4.24M | 2.77M | 4.13M | |||
| OPERATING CASH FLOW | -7.38M | -4.25M | -19.83M | -9.92M | -600.00K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.29M | -1.40M | -1.50M | -1.07M | -1.38M | |||
| Other Investing Activity | -92.00K | -166.00K | -472.00K | -4.14M | -1.08M | |||
| INVESTING CASH FLOW | -1.38M | -1.56M | -1.97M | -5.21M | -2.46M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 2.63M | -1.34M | -1.34M | -962.00K | -772.00K | |||
| Stock Issued/Repurchased | 3.87M | 2.36M | 716.00K | 3.85M | 44.15M | |||
| Dividend Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other Financing Activity | N/A | N/A | 0.00 | -5.00K | N/A | |||
| FINANCING CASH FLOW | 6.50M | 1.02M | -621.00K | 2.88M | 43.38M | |||
| Exchange Rate Effect | -226.00K | -33.00K | 740.00K | 455.00K | -1.18M | |||
| CHANGE IN CASH | -2.48M | -4.82M | -21.68M | -11.79M | 39.15M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -7.38M | -4.25M | -19.83M | -9.92M | -600.00K | |||
| Capital Expenditure | -1.29M | -1.40M | -1.50M | -1.07M | -1.38M | |||
| FREE CASH FLOW | -8.67M | -5.64M | -21.33M | -10.99M | -1.98M | |||
All data in CAD